Daiichi Sankyo is poised to report significantly lower full-year profit for fiscal year 2025, primarily due to a 95 billion Japanese yen ($610 million) hit linked to its precautionary antibody-drug ...

With traditional ADCs now fulfilling their potential to reshape the standard of oncology care, the bioconjugate community is doubling down on differentiation to ensure the next wave of ADCs delivers ...

You may have noticed an officer standing just behind the President of India at official events, state visits, or ceremonial functions. That officer holds a very important role as an Aide-de-Camp (ADC) ...

7MW4911, a CDH17-targeting ADC, received FDA IND clearance for Phase I/II trials in advanced colorectal and GI tumors, addressing significant unmet needs. The ADC uses Mabwell's IDDC™ platform, ...

As speculations intensify over who emerges as the presidential candidate of the African Democratic Congress ahead of the 2027 general elections, the party’s leadership has insisted its immediate ...

ABUJA – In a bold move to reposition itself as a credible opposition platform, the African Democratic Congress (ADC) has approved the appointment of several prominent political figures, including ...

After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

The pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects. There is still more work to be done to refine ...

Abstract: In the field of ADC testing, static parameters are parameters that characterize the quantized voltage and the standard quantized voltage of the ADC at certain points in the range. So the ...

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

As a creative individual, Jordan Tassiello has a track record of achievements in founding her own business and working with large companies on writing, editing, design, content creation and campaigns.

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the low ...